Smith, Moore & Co’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
18,620
-133
-0.7% -$8.32K 0.08% 202
2026
Q1
$1.16M Buy
18,753
+2,315
+14% +$150K 0.08% 188
2025
Q4
$1.07M Buy
16,438
+1,120
+7% +$70.7K 0.08% 196
2025
Q3
$899K Buy
15,318
+488
+3% +$27.8K 0.07% 223
2025
Q2
$838K Buy
14,830
+634
+4% +$35.8K 0.07% 230
2025
Q1
$864K Buy
14,196
+87
+0.6% +$5.32K 0.08% 220
2024
Q4
$822K Buy
14,109
+828
+6% +$51.2K 0.08% 216
2024
Q3
$863K Sell
13,281
-48
-0.4% -$3.07K 0.08% 201
2024
Q2
$817K Buy
13,329
+1
+0% +$60 0.08% 196
2024
Q1
$825K Sell
13,328
-187
-1% -$11.2K 0.09% 196
2023
Q4
$774K Buy
13,515
+5
+0% +$272 0.09% 191
2023
Q3
$730K Hold
13,510
– – 0.1% 188
2023
Q2
$757K Buy
13,510
+5
+0% +$278 0.1% 191
2023
Q1
$738K Buy
13,505
+500
+4% +$27.4K 0.1% 187
2022
Q4
$738K Buy
13,005
+370
+3% +$20.4K 0.1% 189
2022
Q3
$639K Buy
12,635
+1,275
+11% +$68.9K 0.1% 195
2022
Q2
$611K Buy
11,360
+5
+0% +$274 0.09% 204
2022
Q1
$656K Hold
11,355
– – 0.09% 210
2021
Q4
$682K Buy
11,355
+5
+0% +$286 0.09% 206
2021
Q3
$626K Hold
11,350
– – 0.1% 210
2021
Q2
$619K Hold
11,350
– – 0.09% 213
2021
Q1
$573K Buy
11,350
+5
+0% +$251 0.09% 213
2020
Q4
$558K Hold
11,345
– – 0.1% 191
2020
Q3
$515K Buy
11,345
+5
+0% +$226 0.11% 188
2020
Q2
$489K Buy
11,340
+1,625
+17% +$68.6K 0.11% 176
2020
Q1
$365K Buy
9,715
+445
+5% +$18.3K 0.1% 191
2019
Q4
$400K Sell
9,270
-250
-3% -$10.1K 0.08% 207
2019
Q3
$360K Buy
9,520
+5
+0.1% +$192 0.08% 216
2019
Q2
$372K Sell
9,515
-680
-7% -$25.7K 0.08% 223
2019
Q1
$395K Sell
10,195
-945
-8% -$35.9K 0.09% 205
2018
Q4
$403K Buy
11,140
+5
+0% +$192 0.11% 190
2018
Q3
$452K Buy
11,135
+620
+6% +$23.9K 0.1% 188
2018
Q2
$375K Sell
10,515
-555
-5% -$19.6K 0.09% 200
2018
Q1
$382K Sell
11,070
-410
-4% -$14.8K 0.1% 192
2017
Q4
$400K Sell
11,480
-750
-6% -$26K 0.11% 187
2017
Q3
$420K Buy
12,230
+100
+0.8% +$3.37K 0.12% 178
2017
Q2
$403K Buy
12,130
+685
+6% +$21.9K 0.14% 145
2017
Q1
$356K Sell
11,445
-1,460
-11% -$44.6K 0.13% 158
2016
Q4
$372K Buy
12,905
+190
+1% +$5.51K 0.14% 143
2016
Q3
$382K Hold
12,715
– – 0.15% 129
2016
Q2
$377K Sell
12,715
-325
-2% -$9.49K 0.16% 129
2016
Q1
$367K Buy
13,040
+175
+1% +$4.84K 0.16% 124
2015
Q4
$386K Sell
12,865
-175
-1% -$5.2K 0.19% 101
2015
Q3
$365K Hold
13,040
– – 0.2% 92
2015
Q2
$414K Hold
13,040
– – 0.21% 89
2015
Q1
$402K Sell
13,040
-360
-3% -$10.9K 0.21% 88
2014
Q4
$386K Sell
13,400
-5
-0% -$141 0.21% 95
2014
Q3
$360K Sell
13,405
-500
-4% -$13.2K 0.2% 94
2014
Q2
$356K Buy
13,905
+5
+0% +$123 0.22% 83
2014
Q1
$342K Hold
13,900
– – 0.2% 97
2013
Q4
$324K Buy
+13,900
New +$313K 0.2% 103

Other funds holding IYH

Smith, Moore & Co's IYH Position: Q2 2026 in Review

Smith, Moore & Co reduced its iShares US Healthcare ETF (IYH) stake by 0.71% in Q2 2026, selling an estimated $8.32K and leaving 18,620 shares worth $1.25M. The position accounts for 0.08% of the portfolio, ranked #202.

Smith, Moore & Co first reported a position in IYH in Q4 2013 and has held it in 51 quarters since. 534 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Smith, Moore & Co held 18,620 shares of iShares US Healthcare ETF worth $1.25M as of Q2 2026.
  • Smith, Moore & Co sold 133 iShares US Healthcare ETF shares in Q2 2026, an estimated $8.32K.
  • iShares US Healthcare ETF made up 0.08% of Smith, Moore & Co's portfolio in Q2 2026, its #202 holding.
  • Smith, Moore & Co first reported a position in iShares US Healthcare ETF in Q4 2013 and has held it in 51 quarters since.
  • 534 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.